Heron Therapeuti (HRTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $59.08M
Last updated: Nov 17, 2026 at 11:06 AM ET
Heron Therapeuti (HRTX) Competitors
The companies most similar to Heron Therapeuti are Coherus BioSciences (CHRS), Gain Therapeutics (GANX) and Werewolf Therapeutics (HOWL). By market cap, Heron Therapeuti ranks 5th of the 13 companies on this page; TuHURA Biosciences (HURA) is the largest at $88.58M.
Peer Comparison
HRTX's ROIC of -8.4% is above the peer median of -113.0%, and its revenue growth of -7.8% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| Coherus BioSciences Inc (CHRS) | $81.21M | N/A | 1.5x | -253.4% | -144.8% | 23.4% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Werewolf Therapeutics Inc (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| TuHURA Biosciences Inc (HURA) | $88.58M | N/A | N/A | 0.0% | -81.8% | 0.0% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| Pelthos Therapeutics Inc. (PTHS) | $29.24M | N/A | 0.5x | -199.5% | -95.4% | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mereo BioPharma Group PLC ADR (MREO) | $49.11M | N/A | 61.3x | 0.0% | -116.6% | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| RenovoRx Inc (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| Peer median | $49.64M | 11.1x | 2.3x | 0.0% | -113.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Heron Therapeuti, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Coherus BioSciences Inc (CHRS) | Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. | CHRS competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Werewolf Therapeutics Inc (HOWL) | Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. | HOWL competitors |
| TuHURA Biosciences Inc (HURA) | TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases. | HURA competitors |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| Pelthos Therapeutics Inc. (PTHS) | Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. | PTHS competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Mereo BioPharma Group PLC ADR (MREO) | Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases... | MREO competitors |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| RenovoRx Inc (RNXT) | RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. | RNXT competitors |
Frequently Asked Questions About HRTX
Who are Heron Therapeuti's main competitors?
The companies most similar to Heron Therapeuti include Coherus BioSciences (CHRS), Gain Therapeutics (GANX), Werewolf Therapeutics (HOWL), TuHURA Biosciences (HURA) and Spero Therapeutics (SPRO), listed from the closest match.
Who is Heron Therapeuti's biggest competitor?
TuHURA Biosciences (HURA) is the largest of the similar companies at $88.58M; Coherus BioSciences (CHRS) is the closest match by business profile, size, sector and industry.
How does HRTX stock compare with its competitors?
HRTX's P/S is 0.4x against a peer median of 2.3x; its net margin is -14.5% against a peer median of 0.0%.
Which of Heron Therapeuti's competitors pays a higher dividend?
Heron Therapeuti pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Heron Therapeuti bigger than its competitors?
No. Heron Therapeuti is 5th by market cap among the 13 companies on this page; the largest is TuHURA Biosciences (HURA) at $88.58M.
HRTX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors